TRISCEND Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation
Reported from TCT 2021
Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at TCT 2021. They discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.
Authors
No comments yet!